Related Experiment Video

Updated: Nov 26, 2025

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

5.2K

COVID-19 in the paediatric population of Kazakhstan

Dinagul Bayesheva1, Riza Boranbayeva1, Bayan Turdalina2

  • 1J. S. C. Astana Medical University, Nur-Sultan, Kazakhstan.

Paediatrics and International Child Health
|December 14, 2020
PubMed

Insights

COVID-19 in Kazakhstan children was mostly asymptomatic or mild. Of 650 pediatric cases, 85.8% showed no symptoms, with only three requiring intensive care and no deaths reported.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Epidemiology

Background:

  • First study on COVID-19 pediatric cases in Kazakhstan and Central Asia.
  • Analyzes epidemiological data of coronavirus disease 2019 (COVID-19) in children.
  • Focuses on Kazakhstan's unique demographic and health landscape.

Purpose of the Study:

  • To analyze the epidemiological characteristics of COVID-19 in pediatric patients in Kazakhstan.
  • To describe the clinical presentation, symptoms, and outcomes of COVID-19 in children.
  • To assess the severity and complications of COVID-19 in different pediatric age groups.

Main Methods:

  • Retrospective analysis of 650 pediatric patients diagnosed with COVID-19.
  • Collection and analysis of demographic, epidemiological, and clinical data.
  • Sub-division of children into neonates/infants, young children, older children, and adolescents.

Main Results:

  • Majority of cases (85.8%) were asymptomatic; only 0.6% were severe.
  • Common symptoms included cough (14.8%), sore throat (12.8%), and fever (9.1%).
  • Three children required intensive care; one had acute respiratory distress syndrome; no deaths occurred.

Conclusions:

  • COVID-19 infection in Kazakhstan's children is predominantly asymptomatic or mild.
  • Severe cases and critical outcomes are rare in the pediatric population.
  • The findings highlight the generally favorable prognosis of COVID-19 in children in this region.

Keywords:
COVID-19clinical featurescoronavirusepidemiological features

More Related Videos

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.6K
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Published on: February 9, 2011

23.4K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
110
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
135
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
109
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
90
Primary Healthcare Services01:30

Primary Healthcare Services

Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
1.7K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.7K